These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6119970)

  • 1. [Demyelinating diseases and the cerebrospinal fluid cytoproteinogram].
    Limongi JC; Machado LR; Spina-França A
    Arq Neuropsiquiatr; 1981 Sep; 39(3):296-300. PubMed ID: 6119970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid analysis in the context of CNS demyelinating diseases.
    Matas SL; Glehn Fv; Fernandes GB; Soares CA
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):685-8. PubMed ID: 24141505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CSF-protein in neuromyelitis optica (author's transl)].
    Krause KH; Berlit P; Schmitt HP; von Kummer R
    Fortschr Neurol Psychiatr; 1982 Apr; 50(4):133-8. PubMed ID: 7095722
    [No Abstract]   [Full Text] [Related]  

  • 4. [Demyelinating diseases in children with acute neurological symptoms].
    Olofsson IA; Skov L; Miranda MJ
    Ugeskr Laeger; 2015 Dec; 177(50):V07150587. PubMed ID: 26651911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelopathies: behavior of cerebrospinal fluid cells and proteins].
    Spina-França A; Limongi JC; Berger A
    Arq Neuropsiquiatr; 1981 Jun; 39(2):143-8. PubMed ID: 6169326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid and neuropathological study in Devic's syndrome. Evidence of intrathecal immune activation.
    Leonardi A; Arata L; Farinelli M; Cocito L; Schenone A; Tabaton M; Mancardi GL
    J Neurol Sci; 1987 Dec; 82(1-3):281-90. PubMed ID: 3440870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system.
    Matute-Blanch C; Montalban X; Comabella M
    Handb Clin Neurol; 2017; 146():67-84. PubMed ID: 29110780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demyelinating disorders].
    Savransky A
    Medicina (B Aires); 2018; 78 Suppl 2():75-81. PubMed ID: 30199370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
    Peng L; Bi C; Xia D; Mao L; Qian H
    Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.
    Cohen SR; Herndon RM; McKhann GM
    N Engl J Med; 1976 Dec; 295(26):1455-7. PubMed ID: 995142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinase and peptidase activities of human cerebrospinal fluid in multiple sclerosis.
    Riekkinen PJ; Rinne UK
    Acta Neurol Scand; 1967; 43(S31):182. PubMed ID: 5583255
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic significance of cereborspinal-fluid examinations in myelopathy.
    Gårde A; Kjellin KG
    Acta Neurol Scand; 1971; 47(5):555-68. PubMed ID: 4110749
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation between the cytology and the protein pattern of the cerebrospinal fluid and certain clinical parameters in multiple sclerosis. Analysis of 185 cases].
    Stenuit J
    Acta Neurol Belg; 1972; 72(4):265-78. PubMed ID: 4120108
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.
    Lisak RP; Zweiman B
    N Engl J Med; 1977 Oct; 297(16):850-3. PubMed ID: 904660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Wingerchuk DM; Lucchinetti CF
    Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the spectrum of demyelinating disease in Western Australia.
    Wu JS; Zhang MN; Carroll WM; Kermode AG
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of immunoglobulins in cerebrospinal fluid.
    Takase S; Yoshida M
    Tohoku J Exp Med; 1969 Jun; 98(2):189-98. PubMed ID: 4185860
    [No Abstract]   [Full Text] [Related]  

  • 19. [Magnetic resonance imaging and clinical features in adults with monophasic demyelinating disease. Acute disseminated encephalomyelitis or a variant of multiple sclerosis?].
    Reis F; Kobayashi E; Maciel EP; Zanardi Vde A; Netto JR; Damasceno BP; Cendes F
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):853-9. PubMed ID: 10751923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
    Gudbjornsson BT; Haraldsson Á; Einarsdóttir H; Thorarensen Ó
    Pediatr Neurol; 2015 Dec; 53(6):503-7. PubMed ID: 26463471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.